Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should You Buy or Sell Gilead Sciences Stock? Get The Latest GILD Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
Pacer Advisors Inc. decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 0.6% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,625,845 shares of the biopharmaceutical company’s stock after selling 15,231 shares during the period. Gilead Sciences makes up approximately 1.2% of […]
Institute for Wealth Management LLC. trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 5.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,569 shares of the biopharmaceutical company’s stock after selling 400 shares during the period. Institute for Wealth […]
Nisa Investment Advisors LLC decreased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 3.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 379,768 shares of the biopharmaceutical company’s stock after selling 15,192 shares during the quarter. Nisa […]
Arista Networks (NYSE:ANET – Get Rating) had its price target lifted by Morgan Stanley from $140.00 to $150.00 in a research note issued to investors on Friday, The Fly reports. They currently have an equal weight rating on the technology company’s stock. Several other research firms have also issued reports on ANET. Barclays lifted their […]